Dr Thomas Walter
- Spécialité
- Oncologue médical, expert côlon, poumon et thyroïde
- Titre
- Chef de service
- Hôpital
- Hôpital Edouard Herriot (Lyon)
- Derniers articles
-
- [(177)Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial. (18 juil. 2026)
- Deep learning analysis of breast cancer histology predicts ATM pathogenic variant carrier status. (15 juin 2026)
- Correction: A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217). (13 juin 2026)
- Structural and functional mapping of protective human monoclonal antibodies against enterovirus A71. (5 juin 2026)
- Neuroendocrine tumours through an epigenetic lens: Emerging insights for diagnosis and treatment. (1 juin 2026)